Neurosteroid analogues. 15. A comparative study of the anesthetic and GABAergic actions of alphaxalone, Δ16-alphaxalone and their corresponding 17-carbonitrile analogues
Graphical abstract
Section snippets
Acknowledgments
This work was supported by NIH Grant GM47969 (D.F.C., A.S.E., C.F.Z.) and the Bantly Foundation. X-ray crystal structures were made possible by NSF Shared Instrument Grant No. CHE-042097.
References and notes (27)
J. Steroid Biochem.
(1975)Biochem. Pharmacol.
(1979)- et al.
Biochim. Biophys. Acta
(1986) - et al.
Biochim. Biophys. Acta
(1994) - et al.
Biochim. Biophys. Acta
(1995) - et al.
Biochim. Biophys. Acta
(1997) - et al.
Anesthesiology
(1975) - et al.
J. Med. Chem.
(1965) - et al.
Mol. Pharmacol.
(1975)
J. Neurosci. Res.
J. Med. Chem.
Biochemistry
Cited by (15)
GABA allosteric modulators: An overview of recent developments in non-benzodiazepine modulators
2019, European Journal of Medicinal ChemistryCitation Excerpt :The modification of alphaxalone into Δ16-alphaxalone gives an analog (Fig. 17) that shows a lack of anesthetic effects in humans and significantly diminishes GABA receptor activity [119–121]. The corresponding 17β-carbonitrile analog of alphaxalone (69, Fig. 17) and the Δ16-17-carbonitrile analogs (70, Fig. 17) were investigated for receptor selectivity and anesthetic activity [122]. The discrepancy effect of Δ16-double bond on the actions of alphaxalone and the 17β-carbonitrile analog is described for by a different orientation of 17-acetyl and 17-carbonitrile substituents [122].
Inhibitable photolabeling by neurosteroid diazirine analog in the β3-Subunit of human hetereopentameric type A GABA receptors
2019, European Journal of Medicinal ChemistryCitation Excerpt :The EC50 of alphaxalone alone was found to be 1.4 ± 0.3 μM and the slope of the curve was 3.1 ± 1.2. This is consistent with the published EC50s of 1–2 μM and slopes 1.7 to 3.4 [22,27]. 21-pTFDBzox-AP at 2.5 μM caused a small shift of anesthetic EC50 of alphaxalone from 1.4 ± 0.3 to 0.92 ± 0.3 μM, which was significant (F-test, F = 8.174, p = 0.005).
Synthesis and pharmacological evaluation of neurosteroid photoaffinity ligands
2017, European Journal of Medicinal ChemistryCitation Excerpt :Both F4N3Bzox-AP and 11-aziAP are potent allosteric effectors of GABAA receptors whose binding site is distinct from, but allosterically coupled to, those of both etomidate and R-mTFD-MPAB. The fact that a large substitution at the 11-position of the steroid framework does not compromise its interactions with the GABA receptor is consistent with the established SAR [10–14]. Nonetheless, the observed photolabeling was not pharmacologically specific.
Steroids Bearing Heteroatom as Potential Drugs for Medicine
2023, BiomedicinesRecent Advances Towards Syntheses of Diterpenoid Alkaloids
2019, Synthesis (Germany)Synthesis of <sup>13</sup> C-Labeled Steroids
2019, Synthesis (Germany)